慢性鼻窦炎药物与手术治疗后症状域与生产力变化的相关性
本研究前瞻性纳入202例难治性慢性鼻窦炎(CRS)患者,比较继续药物治疗(CAMT,39例)与内镜鼻窦手术(ESS,163例)后症状域变化与生产力损失的相关性。ESS组SNOT-22总分及各症状域均改善(均p<0.001),平均生产力损失显著减少(-$5,015,p<0.001);CAMT组仅SNOT-22总分和鼻科症状域改善(均p≤0.039),生产力损失几乎不变(-$200,p=0.887)。
要点
- ESS组术后SNOT-22总分及各症状域均改善,生产力损失显著减少。
- CAMT组仅鼻科症状域改善,生产力损失无显著变化。
- CAMT组基线生产力优于ESS组,且治疗期间维持该水平。
核心结论
- 不同治疗方式与不同的治疗后生产力变化相关。
- 选择ESS的患者术后生产力改善分布于所有SNOT-22症状域,提示生产力改善与多个症状域相关。
- 选择CAMT的患者基线生产力优于选择ESS的患者,且该生产力水平在治疗期间得以维持。
- SNOT-22鼻外、心理和睡眠症状域评分更差的患者生产力损失更大。
研究设计与样本
- 前瞻性观察性多机构队列研究,纳入202例成人难治性慢性鼻窦炎患者,2012年8月至2015年6月入组。
- 患者提供治疗前后22项鼻窦结果测试(SNOT-22)评分。
- 生产力损失通过缺勤、出勤主义、休闲时间损失及美国政府估算的工资和劳动率货币化。
主要发现
- 39例(19%)选择继续适当药物治疗(CAMT),163例(81%)选择内镜鼻窦手术(ESS)。
- CAMT组SNOT-22总分和鼻科症状域评分改善(均p≤0.039)。
- ESS组SNOT-22总分及所有症状域改善(均p<0.001)。
- CAMT组平均货币化生产力损失几乎不变(-$200,p=0.887),ESS组显著减少(-$5,015,p<0.001)。
- CAMT组中鼻外、心理和睡眠症状域平均治疗后评分更差者报告的平均生产力损失更大,但无统计学显著线性相关(r≤0.249;p≥0.126)。
临床怎么用
- 对于难治性CRS患者,ESS可能带来更广泛症状域改善及生产力提升。
- CAMT可维持基线生产力,但生产力损失改善不显著。
- 评估生产力损失时应关注鼻外、心理和睡眠症状域的严重程度。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Chronic rhinosinusitis (CRS) is associated with substantial productivity losses. Prior cross-sectional study has identified risk factors and symptom subdomains contributing to baseline productivity loss. This study evaluates correlations between posttreatment changes in symptom subdomain and productivity loss. METHODS: A total of 202 adult patients with refractory CRS were prospectively enrolled into an observational, multi-institutional cohort study between August 2012 and June 2015. Respondents provided pretreatment and posttreatment 22-item Sino-Nasal Outcome Test (SNOT-22) scores. Productivity losses were monetized using measures of absenteeism, presenteeism, lost leisure time, and U.S. government-estimated wage and labor rates. RESULTS: A total of 39 (19%) participants elected continued appropriate medical therapy (CAMT) and 163 (81%) elected endoscopic sinus surgery (ESS). CAMT patients experienced improvement in SNOT-22 total and rhinologic subdomain scores (both p ≤ 0.039). ESS patients reported improvement in SNOT-22 total scores and all subdomains (all p < 0.001). Mean monetized productivity losses were nearly unchanged following CAMT (-$200, p = 0.887) but significantly reduced following ESS (-$5,015, p < 0.001). Mean productivity losses were reported in CAMT patients reporting worse mean posttreatment extra-rhinologic, psychological, and sleep symptom severity scores; however, no statistically significant linear correlations (r ≤ 0.249; p ≥ 0.126) were reported. CONCLUSION: Treatment modalities associate with different posttreatment productivity changes. Patients electing ESS experienced postoperative improvement in productivity distributed across all SNOT-22 symptom domains, suggesting productivity improvement correlates with multiple symptom domains. Patients electing CAMT had better baseline productivity compared to patients electing ESS, and this productivity level was maintained through treatment. Greater productivity loss occurred in patients with worse SNOT-22 scores in the extra-rhinologic, psychological, and sleep subdomains.
引用
- Beswick DM, Mace JC, Rudmik L, et al. Productivity changes following medical and surgical treatment of chronic rhinosinusitis by symptom domain. Int Forum Allergy Rhinol. 2018. PMID: 30054977. doi:10.1002/alr.22191
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。